Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.
Vicinitas Therapeutics has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in July 2022.
Vicinitas Therapeutics's investors include Andreessen Horowitz, Google Ventures, Deerfield, Berkeley Catalyst Fund (BCF), Droia Ventures.
Vicinitas Therapeutics is headquartered in San Francisco, United States.
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.
Vicinitas Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vicinitas Therapeutics — Funding & Investors." VCBacked, July 28, 2022, https://www.vcbacked.co/company/vicinitas-therapeutics. Accessed September 2, 2026.
VCBacked. (2022). Vicinitas Therapeutics — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/vicinitas-therapeutics
{{cite web |title=Vicinitas Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vicinitas-therapeutics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated